LFCR profile · all as-reported value updates

LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) as-reported value updates

Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.

Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.

Rows publish only when the later filed value differs by at least 1.0% and at least $1,000,000, after dropping differences that match under the capped trailing-zero precision rule. The delta percent is delta divided by the larger absolute filed value. Values are annual standardized facts only; metrics whose differences fall below those thresholds or match the capped precision rule are not published as rows.

Ledger table figure

Metric	FY	Earliest XBRL-filed value	Currently on file	Difference	Difference %	Label	Filing links	Notes
Revenue RevenueFromContractWithCustomerIncludingAssessedTax	2021	544,161,000 filed 2021-07-29 · 10-K	100,874,000 filed 2024-03-20 · 10-K	-443,287,000	-81.46%	revised comparative figure	0001005286-21-000043 0001005286-24-000030	4 filed observations examined for this concept and period.
Revenue RevenueFromContractWithCustomerIncludingAssessedTax	2020	590,366,000 filed 2020-08-14 · 10-K	160,066,000 filed 2023-03-16 · 10-K/A	-430,300,000	-72.89%	revised comparative figure	0001005286-20-000004 0001005286-23-000055	4 filed observations examined for this concept and period.
Operating income OperatingIncomeLoss	2022	-41,294,000 filed 2022-09-14 · 10-K	-11,791,000 filed 2024-08-26 · 10-K	29,503,000	+71.45%	revised comparative figure	0001005286-22-000047 0001005286-24-000124	4 filed observations examined for this concept and period.
Capital expenditures PaymentsToAcquirePropertyPlantAndEquipment	2020	26,686,000 filed 2020-08-14 · 10-K	12,214,000 filed 2023-03-16 · 10-K/A	-14,472,000	-54.23%	revised comparative figure	0001005286-20-000004 0001005286-23-000055	4 filed observations examined for this concept and period.
Gross profit GrossProfit	2021	81,474,000 filed 2021-07-29 · 10-K	38,937,000 filed 2024-03-20 · 10-K	-42,537,000	-52.21%	revised comparative figure	0001005286-21-000043 0001005286-24-000030	4 filed observations examined for this concept and period.
Gross profit GrossProfit	2020	74,988,000 filed 2020-08-14 · 10-K	39,387,000 filed 2023-03-16 · 10-K/A	-35,601,000	-47.48%	revised comparative figure	0001005286-20-000004 0001005286-23-000055	4 filed observations examined for this concept and period.
Revenue RevenueFromContractWithCustomerIncludingAssessedTax	2022	185,786,000 filed 2022-09-14 · 10-K	111,270,000 filed 2024-08-26 · 10-K	-74,516,000	-40.11%	revised comparative figure	0001005286-22-000047 0001005286-24-000124	4 filed observations examined for this concept and period.
Operating income OperatingIncomeLoss	2021	-13,496,000 filed 2021-07-29 · 10-K	-8,823,000 filed 2024-03-20 · 10-K	4,673,000	+34.63%	revised comparative figure	0001005286-21-000043 0001005286-24-000030	4 filed observations examined for this concept and period.
Operating income OperatingIncomeLoss	2020	-38,537,000 filed 2020-08-14 · 10-K	-25,876,000 filed 2023-03-16 · 10-K/A	12,661,000	+32.85%	revised comparative figure	0001005286-20-000004 0001005286-23-000055	4 filed observations examined for this concept and period.
Gross profit GrossProfit	2022	50,370,000 filed 2022-09-14 · 10-K	39,066,000 filed 2024-08-26 · 10-K	-11,304,000	-22.44%	revised comparative figure	0001005286-22-000047 0001005286-24-000124	4 filed observations examined for this concept and period.
Capital expenditures PaymentsToAcquirePropertyPlantAndEquipment	2021	23,769,000 filed 2021-07-29 · 10-K	19,264,000 filed 2023-03-16 · 10-K/A	-4,505,000	-18.95%	revised comparative figure	0001005286-21-000043 0001005286-23-000055	3 filed observations examined for this concept and period.
Stockholders' equity StockholdersEquity	2022	107,945,000 filed 2022-09-14 · 10-K	87,823,000 filed 2024-08-26 · 10-K	-20,122,000	-18.64%	revised comparative figure	0001005286-22-000047 0001005286-24-000124	4 filed observations examined for this concept and period.
Net income NetIncomeLoss	2022	-97,431,000 filed 2022-09-14 · 10-K	-116,715,000 filed 2024-08-26 · 10-K	-19,284,000	-16.52%	revised comparative figure	0001005286-22-000047 0001005286-24-000124	4 filed observations examined for this concept and period.
Operating cash flow NetCashProvidedByUsedInOperatingActivities	2021	15,017,000 filed 2021-07-29 · 10-K	16,471,000 filed 2024-03-20 · 10-K	1,454,000	+8.83%	revised comparative figure	0001005286-21-000043 0001005286-24-000030	4 filed observations examined for this concept and period.
Operating cash flow NetCashProvidedByUsedInOperatingActivities	2022	-24,399,000 filed 2022-09-14 · 10-K	-22,593,000 filed 2024-08-26 · 10-K	1,806,000	+7.40%	revised comparative figure	0001005286-22-000047 0001005286-24-000124	4 filed observations examined for this concept and period.
Gross profit GrossProfit	2016	70,957,000 filed 2016-08-01 · 10-K	66,781,000 filed 2018-08-09 · 10-K	-4,176,000	-5.89%	revised comparative figure	0001437749-16-036012 0001437749-18-015135	4 filed observations examined for this concept and period.
Gross profit GrossProfit	2017	83,186,000 filed 2017-08-11 · 10-K	79,212,000 filed 2019-08-01 · 10-K	-3,974,000	-4.78%	revised comparative figure	0001437749-17-014444 0001628280-19-009791	4 filed observations examined for this concept and period.
Capital expenditures PaymentsToAcquirePropertyPlantAndEquipment	2016	40,867,000 filed 2016-08-01 · 10-K	39,695,000 filed 2018-08-09 · 10-K	-1,172,000	-2.87%	revised comparative figure	0001437749-16-036012 0001437749-18-015135	4 filed observations examined for this concept and period.